Therefore, understanding the relationship between ADAM17 function and the JAK/STAT pathway in diabetes and neurodegenerative diseases can provide insights into potential therapeutic strategies targeting this interplay to alleviate disease symptoms and progression. Here, ADAM17 is linked to neurodegenerative disease.